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Abstract
In conventional GWA studies, only one of monozygotic twin(MZ) pairs are
considered because of same genetic information that we fomulate new method
for gene-mapping study using resemblance information of phenotypes between
MZ cotwins. Our new method used MZ concordance information as dependent
variable(binomial trait) that Cochran-Amitage trend test(no covariate) or logis-
tic regression(with covariate) was applied. Considering serum triglyceride(TG)
or Hypertriglycedemia(hyperTG) traits and rs651821, well-known TG related
SNP, power of our association test was calculated via creating simulated pheno-
types and we apply our approach to 399 real MZ pairs in Healthy Twin Study,
Korea and compare p-value with that of result of GWAS using 1,819 individuals
including family structures. In result, rs651821 has some trend with hyperTG
traits but is not significant in various hyperTG cutoffs as 120, 150, 180, 210,
240(range of p-value: 0.003-0.176). But compared with conventional GWAS in
whole autosomal chromosome levels(537,158 SNPs), The authors find positive
association in our new approach and GWAS’s results using ROC curves and
AUC values. Our methods using new information that concordance of MZ or
probability of at least 1 MZ cotwin are affected can contribute gene mapping
study.
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Recently genome-wide association studies have become a standard gene map-
ping method, but some limitations like Lack of well defined case and control
groups, insufficient sample size, control for multiple testing problem, control for
population stratification and “missing heritability” are issued[1, 2, 3].
Meanwhile, MZs have been either considered to be redundant or treated as
unrelated individuals after randomly selecting one cotwin. It has been a com-
mon sense in academia that monozygotic twin (MZ) pairs, although they have
unique strengths in detecting non-genomic etiology, do not contribute to gene
mapping studies.
It is indeed true for linkage analysis, but resemblance of phenotypes between MZ
cotwins does include information about linkage disequilibrium (LD) between
the genetic markers and postulated disease-susceptibility loci (DSL) when the
concordance/discordance rates or probability of twin has disease are compared
across genotypes. For example, if a disease and disease susceptible loci(DSL)
are highly penetrated in population, probability of both MZ are affected is in-
1
creased when number of disease suscetible alleles are increased (assuming ad-
ditive model). But with low penetrance, above explanation isn’t appropriated
that we can probability of at least one of MZtwin is affected instead of proba-
bility of both MZ are affected.
This approach provides new information about DSL and contributes gene map-
ping stuidies, so Some GWAS limitations like power, control of multiple testing
is improved via meta analysis and screening test[3, 4].
We attempted to formulate a method to detect association and suggest several
ways of applying the information using hypertriglyceridemia as a model pheno-
type. At first, We find DSL using trivial GWAS study from the Healthy Twin
Study, korea which do not utilize MZ information. And we perform power cal-
culation of our method via creating MZ phenotype(eg, concordance or at least
one is affected) of various scenario using DSL information and genotype data
of founder in Healthy Twin Study. Last, We apply our methods to DSL and






Healthy Twin Study, Korea is used in our study. This data includes 3,461 Ko-
rean families with 493 MZs and 537,158 SNPs in all autosomal chromosome
genotyping with Affymetrix 6.0. We assume that genotypes of MZs are same
and only one twin is genotyped.
2.2 Notation
It is natural to assume that if allele D (wild type allele is +) is in LD with true
DSL, so genotypes are DD, D+ and ++. “A*A” is the proportion of MZ with
both affected, “A*U” is the proportion of MZ with only one affected and “U*U”
is the proportion of MZ with both unaffected. “Obs()” is observed rate and
“prevalence” is prevalence rate among general population or study participants.
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2.3 Our methods
We considered penetrance of diease and only considered additive effect model.
2.3.1 Method 1: Using Twin concordance rate - High pene-
trance model
Assuming disease is highly penetrated in population, if observed loci isn’t as-
sociated with disease, probability of both MZ are affected is square of preva-
lence and probability of both MZ are not affected is square of 1-prevalence.
In contrast, if observed loci has LD with DSL or is associated with disease,
probability of both MZ are affected is increased and probability of both MZ are
not affected are decreased with increasing number of disease susceptible allele.
Manipulating this expression, we therefore obtain hypothesis that
H0 : Obs(A ∗A|DD) = Obs(A ∗A|D+) = Obs(A ∗A|+ +) = (prevalence)2
Obs(U ∗ U |DD) = Obs(U ∗ U |D+) = Obs(U ∗ U |+ +) = (1− prevalence)2
H1 : Obs(A ∗A|DD) > Obs(A ∗A|D+) > Obs(A ∗A|+ +)
Obs(U ∗ U |DD) < Obs(U ∗ U |D+) < Obs(U ∗ U |+ +)
(2.1)
We use only concordant MZ pairs, So hypothesis can be tested with Cochran–Armitage





ti(N1iR2 −N2iR1) (Test statistics for trend test) (2.2)
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++ D+ DD Sum
A ∗A N11 N12 N13 R1
U ∗ U N21 N22 N23 R2
Sum C1 C2 C3 N
Table 2.1 Table for trend test: Method 1
ti : weight(number of risk allele) for trend test ; t1 = 0, t2 = 1, t3 = 2
T has chi-square distribution with 1 df(degree of freedom) assuming H0.
logit(p(A ∗A)) = α0 + α · covariate + β · num(allele D) + ε (2.3)
α0: intercept, α: coefficient vector of covariates, β: coefficient of number of risk
allele, num(allele D): number of risk allele, ε: error
β value is zero when H0.
2.3.2 Method 2: Using probability of the affected exists within
each MZ - Low penetrance model
If disease has low penetrance, similar to above, probability of the affected exist
within each MZ isn’t changed with increasing number of risk allele in null hy-
pothesis and the probability is increased with increasing number of risk allele
in alternative hypothesis. So expression is
H0 : Obs(A ∗AorA ∗ U |DD) = Obs(A ∗AorA ∗ U |D+) = Obs(A ∗AorA ∗ U |+ +)
H1 : Obs(A ∗AorA ∗ U |DD) > Obs(A ∗AorA ∗ U |D+) > Obs(A ∗AorA ∗ U |+ +)
(2.4)
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++ D+ DD Sum
A ∗AorA ∗ U M11 M12 M13 S1
U ∗ U M21 M22 N23 S2
Sum D1 D2 D3 M
Table 2.2 Table for trend test: Method 2




vi(M1iS2 −M2iS1) (Test statistics for trend test) (2.5)
vi : weight(number of risk allele) for trend test ; v1 = 0, v2 = 1, v3 = 2
logit(p(A ∗A or A ∗ U)) = α0 + α · covariate + β · num(allele D) + ε (2.6)
Formula notation and hypothesis test is same to above.
2.4 Conventinal GWAS to find DSL
We find rs651821 (p-value=4.5× 10−15) at chromosme 11 as DSL with triglyc-
eride in whole family samples using FASTA method via R package “GenABEL”
[6, 7]. This TG level-associated SNP is previously reported and we use rs651821
as DSL in our study[8, 9].
2.5 Simulation to calculate power
For performing simulations, we select 481 subset of people in Healthy Twin
Study,Korea as a simulation dataset that are founder and non-missing at rs651821,
assuming one people’s genotype as of two persons of MZ. Next, we create
various binary phenotypes for simulation based on simulation genotype data
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and assuming causal loci and it’s effect size as rs651821 and this SNP’s ef-
fect size in “GenABEL”. We consider various scenario with various heritabil-
ity, prevalence, case:control ratio (heritability: 0.1, 0.2, · · · , 0.8 ; prevalence:
0.05, 0.1, 0.2, 0.3, 0.4 ; proportion of case: 0.05, 0.1, 0.2, 0.3, 0.4, 0.5) that we cre-
ate 200 binary phenotypes for each scenario and calculate proportion of rs651821’s
p-value’s under threshold(e.g 5 × 10−8). Synthetic phenotypes are created by
“GCTA” ver 1.20 and p-value’s are calculated by “PLINK” ver 1.07[10, 11].
2.6 Apply to real MZ data
We apply above methods with 399 MZ pairs in Healthy Twin Study, Korea
and consider various hypertriglycedemia disease cut-offs(120, 150, 180, 210, 240)
with “GenABEL” package with R 3.0.2, compare with previous GWAS’s re-
sult. Finally, We compare our methods with GWAS in whole autosomal SNP
level(537,158 SNPs) using ROC curves. We assume GWAS’s p-values less than
each significant levels (10−3, 10−4, 10−5, 10−6) as event and analyze ROC curve




3.1 Descriptive statistics of study populations
Descriptive informations of 399MZ pairs(157 male) in our study is presented
in Table 3.1 that mean age is 38.87(s.d 7.31) and mean TG is 108.38(s.d
81.67). Number that Both MZ are affected is 71-7 according hyperTG cut-
offs(120,150,180,210,240) and that of at least 1 MZ is affected is 163-44 accord-
ing same cutoffs.
Next, We earn descriptive penetrance information via assuming penetrance as
proportion of affected person(or MZ pairs) in population(or MZ pair) that have
minor allele in rs651821 (Table 3.2). Considering hyperTG phenotype of indi-
viduals in MZ pairs(N=790), penetrance’s are 28.9% to 5.6% according hy-
perTG cutoffs and those are 21.7%-1.9% and 40.1% 10.1% in high penetrance
model and low penetrance model.
8

































Note: Penetrance is calculated as mean of that of 1 risk allele’s and 2 risk alleles case
Table 3.2 Penetrance of various TG related phenotypes
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3.2 Power calculation
Above to method, We calculate powers in various scenarios with 481 person’s
genotypes of rs651821 and synthetic phenotypes (Figure 3.1). We found obvious
trend with heritability that mean power is 0.43, 0.76, 0.86, 0.92, 0.98, 0.997,
0.9998, 1 according 0.1-0.8 heritablity values that power is higher than 0.9
when heritability is greater than 0.4. Power is decreased (0.93-0.81) according
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Figure 3.1 Results of power calculation using synthetic phenotypes
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Model (SNP= rs651821) Cutoff P-value
GWAS(N=1819,trait=TG) 4.5× 10−15










Note: “GWAS” is result of conventional GWAS
Table 3.3 Results of our Methods & meta-analysis
3.3 Apply to MZ data
We apply our method to 399 MZ pairs with various hyperTG cutoffs and that we
find some trend between rs651821 information and various hyperTG traits(p-
value’s range: 0.002-0.176), but any significant results aren’t found(significant
level: 5× 10−8, Table 3.3).
3.4 Compare with conventional GWAS via whole chro-
mosome
We compare p-values of 537,158 SNPs in GWAS and our methods using ROC
curves (Figure 3.2). For various GWAS’s significant levels (10−3, 10−4, 10−5, 10−6),
We analyze ROC curve and area under curve(AUC) values with various cutoffs
12
and methods that low penetrance models have higher AUC values than high
penetrance model(0.69 VS 0.61). There are no obvious trend according cut-
off values (0.65,0.65,0.68,0.61,0.66 when cutoffs are 120,150,180,210,240) and
AUC values are decreased(0.71,0.68,0.61,0.60) with increasing significant levels
(10−3, 10−4, 10−5, 10−6).
13












































































































































































































































In this study, We analyze association of TG like traits and rs651821 with our
method via power calculation, comparing with conventional GWAS’s result,
and compare our methods with GWAS in whole chromosome level.
We calculate TG’s heritability as 0.4 using 1,819 individuals including family
structure, this result and rs651821’s significant p-value(4.5 × 10−15) are com-
patible with power calculation that power is greater than 0.9 when heritability
is greater than 0.4(Figure 3.1). But No sigificant results when applying our
methods with various hyperTG cutoffs(Table 3.3), we think this is because of
some limitations of our study. First, Defining heritability of phenotypes com-
bining MZ information is very hard because our phenotypes are defined only
in MZ. We think unmeasured heritability like status in our scenario is de-
creased because of combining phenotype informations of 2 MZ and this may
affect to non-significant results. Second, information loss because of binomial
transformation of trait that method of analyzing continuous trait is one of our
next chalange. Making new phenotype similar to “Family Based Association
15
Test(FBAT)” is reasonable approach, but normality of new phenotype issue is
problem, so further study is needed to solve this issue[12]. Next, our method’s
phenotype is differ to original binomial trait that new phenotypes in our high &
low penetrance model(concordance information or probability at least one MZ
affected) aren’t direct measure of individual’s TG levels or hyperTG status. In
addition, case proportion and N are decreased when analyzing concordant MZ
pairs(Table 3.1), or this is impossible to separate case of both MZ are affected
with only one of MZ is affected in low penetrance model. Insufficient sample
size and decreased sample due to combining 2 MZ’s information can also affect
non-significant results in various scenario. But most results of ROC curves us-
ing 537,158 SNPs in Figure 3.2 reveal that our approach is positively correlated
with conventional GWAS, many of above issues will be overcome with sufficient
sample size.
In spite of above limitaions, our findings show a way to extract LD information
from MZ concordance or resemblance when one of cotwin was genotyped. Be-
cause the MZ resemblance is independent of other information conventionally
used for GWAS, it can be combined with other results. The test can be also
used to screen markers to alleviate the burden of multiple testing with appro-
priate threshold. Given that the MZ will be ever popularly applied for various
omics studies, the addition of genomic information will facilitate multi-omics
study in twin research.
16
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[7] Wei-Min Chen and Gonçalo R Abecasis. Family-based association tests for
genomewide association scans. The American Journal of Human Genetics,
81(5):913–926, 2007.
[8] Sekar Kathiresan, Cristen J Willer, Gina M Peloso, Serkalem Demissie,
Kiran Musunuru, Eric E Schadt, Lee Kaplan, Derrick Bennett, Yun Li,
Toshiko Tanaka, et al. Common variants at 30 loci contribute to polygenic
dyslipidemia. Nature genetics, 41(1):56–65, 2008.
[9] Aihua Tan, Jielin Sun, Ning Xia, Xue Qin, Yanling Hu, Shijun Zhang,
Sha Tao, Yong Gao, Xiaobo Yang, Haiying Zhang, et al. A genome-wide
association and gene–environment interaction study for serum triglycerides
levels in a healthy chinese male population. Human molecular genetics, 21
(7):1658–1664, 2012.
[10] Jian Yang, S Hong Lee, Michael E Goddard, and Peter M Visscher. Gcta:
a tool for genome-wide complex trait analysis. The American Journal of
Human Genetics, 88(1):76–82, 2011.
[11] Shaun Purcell, Benjamin Neale, Kathe Todd-Brown, Lori Thomas,
Manuel AR Ferreira, David Bender, Julian Maller, Pamela Sklar, Paul IW
De Bakker, Mark J Daly, et al. Plink: a tool set for whole-genome asso-
ciation and population-based linkage analyses. The American Journal of
Human Genetics, 81(3):559–575, 2007.
18
[12] Steve Horvath, Xin Xu, and Nan M Laird. The family based association
test method: strategies for studying general genotype–phenotype associa-
tions. European journal of human genetics: EJHG, 9(4):301–306, 2001.
19
요약
전장유전체 연관성 연구(Genome-wide assocation study, GWAS)가 질병관련
유전자를 찾는 표준 연구가 되어가고 있으나 일란성 쌍둥이는 그들의 완전히
일치하는 유전적 정보 때문에 오직 한명만이 연구대상이 될 수 있다. 이에 저
자는일란성쌍둥이의표현형의일치여부또는둘중하나라도질병에걸린사
건을 새로운 표현형으로 하는 유전자 매핑 연구(gene mapping study) 방법을
제안한다.본연구에서는일란성쌍둥이의표현형일치여부를독립변수로하여
Cochran-Amitage trend test(공변량 없을 때) 또는 로지스틱 회귀분석(공변량
있을 때)을 이용하였다. 혈중 중성지방 또는 고중성지방혈증을 분석할 표현형
으로, 혈청 중성지방과 연관성이 있는 단일염기다형성(SNP)인 rs651821을 대
상으로 시뮬레이션을 이용하여 검정력(power)를 계산하였으며, 이를 한국 가
족-쌍둥이 코호트의 399쌍의 일란성 쌍둥이와 그들의 다양한 고중성지방혈증
기준(120,150,180,210,240)에 따른 표현형에 적용하고 동일 코호트의 1,819명
(가족구조 포함)을 이용한 일반적인 GWAS의 결과와 비교하였는데, rs651821
과 고중성지방혈증이 관련성이 있는 것처럼 보이는 결과를 얻었으나 통계적
으로 유의한 경우를 찾지 못하였다(p-values: 0.003-0.176). 그러나 가족-쌍둥이
코호트에서 분석한 537,158개의 SNP을 이용하여 일반적인 GWAS와 저자의
방법을 ROC curve와 area under curve(AUC) 값을 이용하여 비교해 보았을 때
양의 방향으로 비슷한 경향을 보임을 알 수 있었다. 본 연구에서 제시하고 있
는 일란성 쌍둥이의 표현형의 정보를 이용한 분석 방법이 유전자 매핑 연구에
기여할 수 있을 것으로 기대한다.
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하고싶습니다.서울대학교보건대학원석사과정에서얻은경험과힘을토대로
앞으로 더 발전하는 연구자가 되도록 하겠습니다. 감사합니다.
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